Product logins

Find logins to all Clarivate products below.


Hyaluronic Acid Viscosupplementation | Medtech 360 | Market Analysis | Global | 2016

The global market for HA viscosupplementation will exhibit moderate growth through 2024, driven by rising use of this treatment, especially in the Asia Pacific region. While premium-priced single injection products will continue to become more popular over the forecast period, 3- and 5-injection products will retain their dominance in some countries due to differences in product access, reimbursement, and because there is more clinical data supporting the efficacy of these products.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for the US, Europe, Asia Pacific, and Brazil across a 10-year period.

Related Medtech Insights Reports

Report
Coronary Artery Bypass Graft Devices – Market Insights – United States
The US CABG device market will grow modestly, driven by increasing complex CAD cases and the adoption of surgical technologies. Favorable clinical evidence, particularly in favor of CABG over PCI,…
Report
Biosurgical Agents | Medtech 360 | Market Insights | US | 2024
The biosurgical agent market in the US will observe modest growth through 2032, primarily driven by favorable demographics, rising awareness of the clinical benefits of these products on surgical…
Report
Diagnostic Imaging Systems – Market Insights – Japan
The diagnostic imaging system market in Japan will see slow growth through 2032. Manufacturers in this space are actively introducing technologically advanced products equipped with digital and AI…
Report
Interventional Cardiology Devices | Medtech 360 | Market Insights | Europe | 2023
The European IC device market has been able to recover from the COVID-19 pandemic and is seen as reverting to pre-pandemic sales. Steady uptake of several technologies has supported the IC device…
Report
Aortic Repair Devices | Medtech 360 | Market Analysis | Europe (Supplemental) | 2018
The European market for aortic repair devices will expand at a modest rate, driven primarily by endovascular procedure volume growth and continued development and adoption of aortic stent…